Showing 6971-6980 of 18629 results for "".
Family Planning Clinical Considerations for Patients with Multiple Sclerosis
https://reachmd.com/programs/neurofrontiers/family-planning-clinical-considerations-for-patients-with-multiple-sclerosis/18044/What family planning considerations should be made for our multiple sclerosis patients? Here’s what you need to know.Using AI to Predict MS Progression
https://reachmd.com/programs/neurofrontiers/using-ai-to-predict-ms-progression/26758/Tune in to hear key takeaways from a presentation at the 2024 ECTRIMS Congress that focused on the use of AI to predict MS progression.Evaluating Post-CDK4/6 Therapy in PIK3CA-Mutated Metastatic Breast Cancer
https://reachmd.com/programs/project-oncology/post-cdk46-therapy-pik3ca-mutated-metastatic-breast-cancer/36167/Real-world evidence is critical for guiding post-CDK4/6 treatment decisions in patients with PIK3CA-mutated metastatic breast cancer. That’s why a recent study presented at the 2025 San Antonio Breast Cancer Symposium analyzed treatment patterns, real-world outcomes, and resistance mechanisms followCases From the Real World: 91-Year-Old Patient With Wet AMD and a Submacular Hemorrhage
https://reachmd.com/programs/cme/Cases-From-the-Real-World-91-Year-Old-Patient-With-Wet-AMD-and-a-Submacular-Hemorrhage/33168/Hear how Drs. Danny Mammo and Ted Leng are using second-generation retinal agents to manage patients with PEDs from nAMD.Rise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
https://reachmd.com/programs/medical-industry-feature/rise-in-early-onset-colon-cancer-being-studied-through-single-cell-sequencing/29922/What’s behind the rise in colon cancer in younger patients? Listen to a breakdown of key trends, possible causes, and ongoing research to find answers.Applying Guidelines to Chronic Hand Eczema Care: A Case-Based Approach
https://reachmd.com/programs/dermconsult/applying-guidelines-to-chronic-hand-eczema-care-a-case-based-approach/35921/Chronic hand eczema presents persistent challenges, often driven by overlapping etiologies that complicate diagnosis and management. But by applying the latest guidelines, we can optimize both short- and long-term outcomes for our patients. Here with Dr. Raj Chovatiya to share a real-world patient cCohort 9 of the Phase 2 EV-202 Trial: First-Line Enfortumab Vedotin Plus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
https://reachmd.com/clinical-practice/oncology-hematology/cohort-9-of-the-phase-2-ev-202-trial-first-line-enfortumab-vedotin-plus-pembrolizumab-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma/39779/In cohort 9 of EV-202, first-line enfortumab vedotin plus pembrolizumab showed promising and durable responses in patients with recurrent or metastatic HNSCC.Understanding and Treating Trauma in Pediatric Patients: Key Management Strategies
https://reachmd.com/programs/clinicians-roundtable/understanding-and-treating-trauma-in-pediatric-patients-key-management-strategies/37131/Childhood trauma can profoundly alter brain and behavioral development, making it essential to recognize how trauma differs from other diagnoses like ADHD. Ryan Quigley sits down with Drs. Heather Forkey and Wynne Morgan, who presented on this topic at the 2025 American Academy of Pediatrics NationaTargeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
https://reachmd.com/programs/project-oncology/targeting-ccr4-in-car-associated-peripheral-t-cell-lymphoma/37205/Evaluating Dato-DXd for EGFR-Mutated Advanced NSCLC: Data from a Pooled Analysis
https://reachmd.com/programs/frontlines-non-small-cell-lung-cancer/evaluating-dato-dxd-for-egfr-mutated-advanced-nsclc-data-from-a-pooled-analysis/32940/There was a recent pooled analysis of the TROPION-Lung01 and TROPION-Lung05 studies, which focused on the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients with previously treated EGFR-mutated advanced non-small cell lung cancer (NSCLC). According to the results, Dato-DXd demonstr